Patients find methotrexate the most debilitating drug
Methotrexate is deeply unpopular among patients with inflammatory arthritis because of its adverse effects, a focus group study shows.
Lead author Kathleen Andersen said all 39 patients interviewed for the study, who included Australians, reported adverse effects when on methotrexate.
Ms Andersen, a PhD candidate the department of family medicine at McGill University, Canada, was presenting a poster on the research at the American College of Rheumatology Annual Meeting 2018 in Chicago.
The study detailing patients’ perceptions of adverse effects when taking disease modifying